Anavex Life Sciences (AVXL)

Anavex Life Sciences (AVXL) Stock Price & Analysis


AVXL Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$6.81 - $15.24
Previous Close$6.97
Average Volume (3M)851.48K
Market Cap
Enterprise ValueN/A
Total Cash (Recent Filing)$154.82M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)-10.6
Dec 12, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.66
Shares Outstanding81,951,115
10 Day Avg. Volume1,342,638
30 Day Avg. Volume851,484
Standard Deviation0.23
Financial Highlights & Ratios
Price to Book (P/B)3.98
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-19.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda0.00
Price Target Upside639.71% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Anavex Life Sciences’s price range in the past 12 months?
Anavex Life Sciences lowest stock price was $6.81 and its highest was $15.24 in the past 12 months.
    What is Anavex Life Sciences’s market cap?
    Currently, no data Available
    When is Anavex Life Sciences’s upcoming earnings report date?
    Anavex Life Sciences’s upcoming earnings report date is Dec 12, 2023 which is in 81 days.
      How were Anavex Life Sciences’s earnings last quarter?
      Anavex Life Sciences released its earnings results on Aug 08, 2023. The company reported -$0.14 earnings per share for the quarter, beating the consensus estimate of -$0.167 by $0.027.
        Is Anavex Life Sciences overvalued?
        According to Wall Street analysts Anavex Life Sciences’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Anavex Life Sciences pay dividends?
          Anavex Life Sciences does not currently pay dividends.
          What is Anavex Life Sciences’s EPS estimate?
          Anavex Life Sciences’s EPS estimate is -$0.15.
            How many shares outstanding does Anavex Life Sciences have?
            Anavex Life Sciences has 81,951,120 shares outstanding.
              What happened to Anavex Life Sciences’s price movement after its last earnings report?
              Anavex Life Sciences reported an EPS of -$0.14 in its last earnings report, beating expectations of -$0.167. Following the earnings report the stock price went up 4.557%.
                Which hedge fund is a major shareholder of Anavex Life Sciences?
                Among the largest hedge funds holding Anavex Life Sciences’s share is Sheaff Brock Investment Advisors LLC. It holds Anavex Life Sciences’s shares valued at 177K.


                  Anavex Life Sciences Stock Smart Score

                  The Anavex Life Sciences stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Anavex Life Sciences

                  Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company, which engages in the development of different therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound, ANAVEX2-73, is being developed to treat Alzheimer's and Parkinson's disease and central nervous system diseases, including Rett syndrome. The company was founded by Harvey Lalach and Athanasios Skarpelos on January 23, 2004 and is headquartered in New York, NY.


                  Top 5 ETFs holding AVXL

                  Market Value
                  Smart Score
                  Vanguard Total Stock Market ETF
                  Vanguard Health Care ETF
                  Schwab U.S. Broad Market ETF
                  Fidelity Nasdaq Composite Index ETF
                  Vanguard Russell 3000 ETF
                  Up to five ETFs with an Outperform Smart Score that hold AVXL. The ETFs are listed according to market value of AVXL within the ETF

                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Bioxcel Therapeutics
                  Cyclerion Therapeutics
                  Eton Pharmaceuticals
                  Frequency Therapeutics

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis